Search Results for

Clear All Filters

April 25, 2022 | The American Prospect

Max Moran Fatou Ndiaye

Op-Ed

Congressional OversightPharma

Where's The Congressional Champion On Pharma Patent Abuses?

But for all of this, neither party’s congressional leaders have directly challenged the main legal mechanism that accounts for those high costs—namely, intellectual property. You’d think members of Congress would recognize the political salience of picking a fight with one of the most hated industries in America. So why isn’t anyone on Capitol Hill even talking about intellectual property’s role in driving high drug prices, and taking the PTO to task to do something about it?

April 19, 2022

Aidan Smith

Blog Post

Congressional OversightCorporate CrackdownExecutive Branch

How The Department Of Commerce Can Combat Economic Malaise

Responsible for creating “conditions for economic growth and opportunity,” the full powers of the DOC must be leveraged to combat economic malaise. Since the modern department was established in 1913, the DOC’s powers have generally been neglected and poorly understood. That’s in part reflective of the DOC’s byzantine structure: it’s a seeming grab-bag of agencies that either don’t fit in neatly with any other department, or are located within the DOC as a result of 20th century political knife-fights.